Raiffeisen Bank International AG Takes $624,000 Position in CME Group Inc. (NASDAQ:CME)

Raiffeisen Bank International AG purchased a new stake in CME Group Inc. (NASDAQ:CME - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,694 shares of the financial services provider's stock, valued at approximately $624,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. SJS Investment Consulting Inc. raised its position in shares of CME Group by 570.6% in the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock valued at $26,000 after buying an additional 97 shares in the last quarter. New Age Alpha Advisors LLC raised its holdings in CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares during the last quarter. Financial Life Planners acquired a new stake in CME Group during the fourth quarter worth approximately $32,000. Knuff & Co LLC bought a new stake in CME Group in the fourth quarter valued at $33,000. Finally, Banque Transatlantique SA bought a new position in shares of CME Group in the 4th quarter worth $35,000. Institutional investors own 87.75% of the company's stock.

Insider Transactions at CME Group

In other news, General Counsel Jonathan L. Marcus sold 390 shares of CME Group stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $277.50, for a total value of $108,225.00. Following the completion of the sale, the general counsel now owns 6,708 shares of the company's stock, valued at $1,861,470. The trade was a 5.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Suzanne Sprague sold 1,500 shares of the business's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $256.83, for a total value of $385,245.00. Following the sale, the chief operating officer now directly owns 8,036 shares of the company's stock, valued at approximately $2,063,885.88. This trade represents a 15.73% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 27,884 shares of company stock valued at $7,389,843. 0.30% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on CME shares. Morgan Stanley boosted their target price on CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a research note on Thursday, April 24th. Oppenheimer raised their price objective on CME Group from $269.00 to $279.00 and gave the company an "outperform" rating in a research note on Friday, April 11th. JPMorgan Chase & Co. decreased their price objective on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a report on Thursday, April 24th. Erste Group Bank raised shares of CME Group to a "strong-buy" rating in a research note on Monday, March 17th. Finally, Piper Sandler upped their price target on CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a report on Tuesday, April 8th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average price target of $256.80.

CME Group Stock Performance

Shares of CME traded up $3.87 during mid-day trading on Wednesday, reaching $281.74. The company had a trading volume of 2,220,835 shares, compared to its average volume of 2,183,065. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The stock has a 50 day moving average of $266.65 and a two-hundred day moving average of $247.92. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $286.48. The stock has a market capitalization of $101.53 billion, a P/E ratio of 29.14, a PEG ratio of 6.76 and a beta of 0.45.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.61 by $0.19. The company had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The firm's quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.50 EPS. On average, analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be given a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.77%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's dividend payout ratio is currently 50.30%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.